Journal of Peptide Science · 2018 · 15 citations · 21 references
Life SciencesBiochemistryMicrobiologyAntimicrobial PharmacologyAntimicrobial ResistanceEnzymologyAntifungal AgentsAntifungal ResistanceEnzyme InhibitionFungal MetabolismFungal PathogenesisMultidrug ResistanceAntifungal AntibioticsAntifungal Drug ResistanceAntifungal PeptidesAntifungal Resistance MechanismsDrug Efflux MechanismsFungal Drug ResistanceFungal Enzyme InhibitorsMinimum Inhibitory Concentration Determination
The antifungal activity of 5‐hydroxy‐4‐oxo‐ l ‐norvaline (HONV), exhibited under conditions mimicking human serum, may be improved upon incorporation of this amino acid into a dipeptide structure. Several HONV‐containing dipeptides inhibited growth of human pathogenic yeasts of the Candida genus in the RPMI‐1640 medium, with minimal inhibitory concentration values in the 32 to 64 μg mL −1 range. This activity was not affected by multidrug resistance that is caused by overexpression of genes encoding drug efflux proteins. The mechanism of antifungal action of HONV dipeptides involved uptake by the oligopeptide transport system, subsequent intracellular cleavage by cytosolic peptidases, and inhibition of homoserine dehydrogenase by the released HONV. The relative transport rates determined the anticandidal activity of HONV dipeptides.
21
F. R. Atherton, Cedric H. Hassall, Robert Lambert · Journal of Medicinal Chemistry · 1986 · 568 citations
R. Franz, Steven L. Kelly, David C. Lamb et al. · Antimicrobial Agents and Chemotherapy · 1998 · 335 citations · Full text